Lv11
100 积分 2022-05-16 加入
OK
Functional Characterization and Optimization of Switchable Allogeneic Chimeric Antigen Receptor T Cells for Targeting CD19 and CD20 in B Cell Malignancies
15分钟前
求助中
CD19 CAR T-cell therapy (GLPG5101) for relapsed or refractory B-cell non-Hodgkin lymphoma (ATALANTA-1): phase 1 results from a single-arm, multicentre, phase 1/2 study
1个月前
已完结
Process engineering of natural killer cell-based immunotherapy
1个月前
已完结
REWRITING CELL THERAPY MANUFACTURING: A ONE-STEP WHOLE BLOOD PROCESSING FOR SCALABLE TREG THERAPIES
2个月前
已完结
Next steps in regulatory T cells: Biology and clinical application
2个月前
已完结
Erythrocyte–anti-PD1 conjugates in persons with advanced solid tumors resistant to anti-PD1/PDL1: preclinical characterization and results of a phase 1 trial
2个月前
已完结
Erythrocyte–antibody conjugates to overcome immunotherapy resistance
2个月前
已完结
Production of Extracellular Vesicles Using a CELLine Adherent Bioreactor Flask
2个月前
已完结
Accelerating and optimising CAR T-cell manufacture to deliver better patient products
2个月前
已完结
PRAME-Specific T-Cell Therapy in Advanced Pediatric Nephroblastoma
3个月前
已完结